Long-Term All-Cause and Cause-Specific Mortality in Asymptomatic Patients With CAC ≥1,000
Allison W. Peng(Johns Hopkins University), Michael J. Blaha(University of California San Diego), Albert D. Osei(Johns Hopkins University), Mouaz H. Al‐Mallah(Wayne State University), Mohammadhassan Mirbolouk(Johns Hopkins University), Zeina Dardari(Johns Hopkins University), Leslee J. Shaw(Allegheny College), Olusola A. Orimoloye(Johns Hopkins University), Michael D. Miedema(Abbott Northwestern Hospital), Alan Rozanski(Icahn School of Medicine at Mount Sinai), Omar Dzaye(Johns Hopkins University), Khurram Nasir(Houston Methodist), Matthew J. Budoff(Foundation for Biomedical Research), Daniel S. Berman(Cedars-Sinai Medical Center), John A. Rumberger(Memorial Hermann)
Cited by 137
Related Papers
Heart Disease and Stroke Statistics—2018 Update: A Report From the American Heart Association
|Circulation|2018|7.2k
From Vulnerable Plaque to Vulnerable Patient
|Circulation|2003|2.7k
From Vulnerable Plaque to Vulnerable Patient
|Circulation|2003|2.3k
SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe
|European Heart Journal|2021|1.7k
World Health Organization cardiovascular disease risk charts: revised models to estimate risk in 21 global regions
|The Lancet Global Health|2019|1.2k